tirzepatide safety concerns vs. Semaglutide for Weight Loss Tirzepatide and autoimmune disease: what

For glycemic control in type 2 diabetes, improvements in blood glucose levels typically begin within the first week of treatment, with fasting glucose reductions often noticeable within 24 weeks

So I wanna, you know, repeat some labs and I wanna understand that if, if there's a very clear hypoglycemia, hyperglycemia, insulin resistance, certainly with a complaint of difficulty losing weight, even if they're not overweight, but they feel like they they are, or they're puffy or they feel like there's some, there's some quite classic things that I see that are really metabolic and, and rooted in Mast Cell Activation Syndrome

New research shows promise for Novo Nordisk's IcoSema, a combination of once-weekly insulin icodec and semaglutide currently being tested in people with type 2 diabetes

This can potentially lead to a bunch of issues like headaches, fatigue, and nutrient deficiencies

Composition Ingredients : water, L-carnitine, caffeine, acidity regulators citric acid, sodium citrates